Skip to main content
Nicholas Mercadante, MD, Cardiology, Leominster, MA

NicholasMichaelMercadanteMD

Cardiology Leominster, MA

Physician

Dr. Mercadante is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mercadante's full profile

Already have an account?

  • Office

    100 Hospital Rd
    Suite 3b, Professional Building
    Leominster, MA 01453
    Phone+1 978-534-3179
    Fax+1 978-840-3161

Summary

  • Dr. Nicholas Mercadante is a cardiologist in Leominster, MA and is affiliated with multiple hospitals in the area, including UMass Memorial Medical Center and UMass Memorial HealthAlliance-Clinton Hospital. He received his medical degree from Saint Louis University School of Medicine and has been in practice 34 years. He specializes in adult cardiovascular heart disease.

Education & Training

  • Mount Auburn Hospital
    Mount Auburn HospitalFellowship, Cardiovascular Disease, 1983 - 1985
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1980 - 1983
  • Saint Louis University School of Medicine
    Saint Louis University School of MedicineClass of 1980

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1981 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Press Mentions

  • PursueCare Completes Series B Fundraising Round and Acquires Digital Therapeutics Developed by Pear Therapeutics, Inc
    PursueCare Completes Series B Fundraising Round and Acquires Digital Therapeutics Developed by Pear Therapeutics, IncJanuary 7th, 2024

Professional Memberships